Transplant Diagnostics Market Size, Share & Trends Analysis Report By Test (Molecular Assays, Non-Molecular Assays), By Product, By Application, By Transplant Area, By End Use, By Region, And Segment Forecasts, 2024

Description

Transplant Diagnostics Market Growth & Trends:

The global transplant diagnostics market size is expected to reach USD 9.74 billion by 2030, registering a CAGR of 7.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. An increasing number of patients suffering from chronic diseases frequently leading to organ failure is creating an upsurge in demand for transplant procedures. In addition, the adoption of stem cell therapy and personalized medicine is escalating, thereby influencing demand for transplant diagnostics.

Risks and complexities associated with organ transplants necessitate the need for improved and sophisticated diagnostic tools. Next-Generation Sequencing (NGS) technology is rapidly replacing traditional diagnostic methods, such as serological techniques employed in Human Leukocyte Antigen (HLA) typing, owing to the growing demand for high-throughput diagnostic tools with enhanced accuracy.

Market growth is expected to be restrained by factors such as reimbursement controversies and ethical issues in some parts of the world. In addition, the high cost of performing HLA matching using Polymerase Chain Reaction (PCR) and NGS devices is challenging the growth of the transplant diagnostics market in developing countries.

Transplant Diagnostics Market Report Highlights:

The sequencing-based typing segment is anticipated to witness significant growth from 2024 to 2030. High adoption of NGS is a major factor driving segment growth
North America captured the largest revenue share in 2023 and is expected to maintain its dominance throughout the forecast period due to well-established research infrastructure, increasing healthcare expenditure, high adoption of advanced diagnostic techniques, and growing R&D activities
Asia Pacific is expected to witness significant growth during the forecast period owing to expanding research opportunities, healthcare expenditure, the medical tourism industry, and awareness regarding organ donation

Product Code: 978-1-68038-970-8

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Transplant Diagnostics Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Transplant Diagnostics Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Transplant Diagnostics Market: Test Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Transplant Diagnostics: Test Outlook Analysis, USD Million, 2023 & 2030
4.3. Molecular Assays
- 4.3.1. PCR-based Molecular Assays
  - 4.3.1.1. PCR-based Molecular Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.2. Real-Time PCR
  - 4.3.2.1. Real-Time PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.3. Sequence-based Primer-PCR
  - 4.3.3.1. Sequence-based Primer-PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.4. Sequence-specific Oligonucleotide-PCR
  - 4.3.4.1. Sequence-specific Oligonucleotide-PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.5. Other PCR-based Molecular Assays
  - 4.3.5.1. Other PCR-based Molecular Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Sequencing-based Molecular Assays
- 4.4.1. Sanger Sequencing
  - 4.4.1.1. Sanger Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2. Next Generation Sequencing
  - 4.4.2.1. Next Generation Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3. Other Sequencing-based Molecular Assays
  - 4.4.3.1. Other Sequencing-based Molecular Assays Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Non-molecular Assays
- 4.5.1. Serological Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.5.1.1. Serological Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.2. Mixed Lymphocyte Culture Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.5.2.1. Mixed Lymphocyte Culture Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Transplant Diagnostics Market: Product Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Transplant Diagnostics Market: Product Analysis, USD Million, 2023 & 2030
5.3. Reagents & Consumables
- 5.3.1. Reagents & Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Instruments
- 5.4.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Software and Services
- 5.5.1. Software and Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Transplant Diagnostics Market: Application Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Transplant Diagnostics Market: Application Analysis, USD Million, 2023 & 2030
6.3. Diagnostics Application
- 6.3.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2. Infectious Disease Testing
  - 6.3.2.1. Infectious Disease Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3. Histocompatibility Testing
  - 6.3.3.1. Histocompatibility Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.4. Blood Profiling
  - 6.3.4.1. Blood Profiling Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Research Application
- 6.4.1. Research Application Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Transplant Diagnostics Market: Transplant Area Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Transplant Diagnostics Market: Transplant Area Analysis, USD Million, 2023 & 2030
7.3. Solid Organ Transplantation
- 7.3.1. Kidney Transplantation
  - 7.3.1.1. Kidney Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. Liver Transplantation
  - 7.3.2.1. Liver Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Heart Transplantation
  - 7.3.3.1. Heart Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. Lungs Transplantation
  - 7.3.4.1. Lungs Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.5. Pancreas Transplantation
  - 7.3.5.1. Pancreas Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.6. Other Organs Transplantation
  - 7.3.6.1. Other Organs Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Stem Cell Transplantation
- 7.4.1. Stem Cell Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Soft Tissue Transplantation
- 7.5.1. Soft Tissue Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Bone Marrow Transplantation
- 7.6.1. Bone Marrow Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Transplant Diagnostics Market: End Use Estimates & Trend Analysis

8.1. Segment Dashboard
8.2. Transplant Diagnostics Market: End Use Analysis, USD Million, 2023 & 2030
8.3. Hospitals and Transplant Centers
- 8.3.1. Hospitals and Transplant Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Research and Academic Institutes
- 8.4.1. Research and Academic Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Independent Reference Laboratories
- 8.5.1. Independent Reference Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Transplant Diagnostics Market: Regional Estimates & Trend Analysis

9.1. Transplant Diagnostics Market Share, By Region, 2023 & 2030, USD Million
9.2. North America
- 9.2.1. North America Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.2.2. U.S.
  - 9.2.2.1. U.S. Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.2.3. Canada
  - 9.2.3.1. Canada Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.2.4. Mexico
  - 9.2.4.1. Mexico Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3. Europe
- 9.3.1. Europe Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.2. U.K.
  - 9.3.2.1. U.K. Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.3. Germany
  - 9.3.3.1. Germany Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.4. France
  - 9.3.4.1. France Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.5. Italy
  - 9.3.5.1. Italy Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.6. Spain
  - 9.3.6.1. Spain Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.7. Denmark
  - 9.3.7.1. Denmark Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.8. Sweden
  - 9.3.8.1. Sweden Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.9. Norway
  - 9.3.9.1. Norway Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Asia Pacific
- 9.4.1. Asia Pacific Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.2. Japan
  - 9.4.2.1. Japan Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.3. China
  - 9.4.3.1. China Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.4. India
  - 9.4.4.1. India Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.5. Australia
  - 9.4.5.1. Australia Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.6. South Korea
  - 9.4.6.1. South Korea Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.7. Thailand
  - 9.4.7.1. Thailand Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5. Latin America
- 9.5.1. Latin America Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.2. Brazil
  - 9.5.2.1. Brazil Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.3. Argentina
  - 9.5.3.1. Argentina Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6. Middle East and Africa
- 9.6.1. Middle East and Africa Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6.2. South Africa
  - 9.6.2.1. South Africa Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6.3. Saudi Arabia
  - 9.6.3.1. Saudi Arabia Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6.4. UAE
  - 9.6.4.1. UAE Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6.5. Kuwait
  - 9.6.5.1. Kuwait Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Company Heat Map Analysis
10.4. Company Profiles
- 10.4.1. Thermo Fisher Scientific, Inc.
  - 10.4.1.1. Participant's Overview
  - 10.4.1.2. Financial Performance
  - 10.4.1.3. Product Benchmarking
  - 10.4.1.4. Recent Developments/ Strategic Initiatives
- 10.4.2. Illumina, Inc.
  - 10.4.2.1. Participant's Overview
  - 10.4.2.2. Financial Performance
  - 10.4.2.3. Product Benchmarking
  - 10.4.2.4. Recent Developments/ Strategic Initiatives
- 10.4.3. F. Hoffmann La-Roche Ltd
  - 10.4.3.1. Participant's Overview
  - 10.4.3.2. Financial Performance
  - 10.4.3.3. Product Benchmarking
  - 10.4.3.4. Recent Developments/ Strategic Initiatives
- 10.4.4. Abbott
  - 10.4.4.1. Participant's Overview
  - 10.4.4.2. Financial Performance
  - 10.4.4.3. Product Benchmarking
  - 10.4.4.4. Recent Developments/ Strategic Initiatives
- 10.4.5. QIAGEN
  - 10.4.5.1. Participant's Overview
  - 10.4.5.2. Financial Performance
  - 10.4.5.3. Product Benchmarking
  - 10.4.5.4. Recent Developments/ Strategic Initiatives
- 10.4.6. Bruker
  - 10.4.6.1. Participant's Overview
  - 10.4.6.2. Financial Performance
  - 10.4.6.3. Product Benchmarking
  - 10.4.6.4. Recent Developments/ Strategic Initiatives
- 10.4.7. BD (Becton, Dickinson and Company)
  - 10.4.7.1. Participant's Overview
  - 10.4.7.2. Financial Performance
  - 10.4.7.3. Product Benchmarking
  - 10.4.7.4. Recent Developments/ Strategic Initiatives
- 10.4.8. Werfen (Immucor, Inc.)
  - 10.4.8.1. Participant's Overview
  - 10.4.8.2. Financial Performance
  - 10.4.8.3. Product Benchmarking
  - 10.4.8.4. Recent Developments/ Strategic Initiatives
- 10.4.9. Bio-Rad Laboratories, Inc.
  - 10.4.9.1. Participant's Overview
  - 10.4.9.2. Financial Performance
  - 10.4.9.3. Product Benchmarking
  - 10.4.9.4. Recent Developments/ Strategic Initiatives
- 10.4.10. Omixon Inc.
  - 10.4.10.1. Participant's Overview
  - 10.4.10.2. Financial Performance
  - 10.4.10.3. Product Benchmarking
  - 10.4.10.4. Recent Developments/ Strategic Initiatives

Transplant Diagnostics Market Size, Share & Trends Analysis Report By Test (Molecular Assays, Non-Molecular Assays), By Product, By Application, By Transplant Area, By End Use, By Region, And Segment Forecasts, 2024 - 2030